Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Checkpoint Therapeutics, Inc. See All Filings	D	2024-07-10 16:05:21 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001651407 Filed Document 0001104659-24-078936 Exclusions or Exemptions 506b Accepted Date 2024-07-10 16:05:21 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Checkpoint Therapeutics, Inc. See All Filings	D	2024-02-05 17:00:39 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001651407 Filed Document 0001104659-24-010741 Exclusions or Exemptions 506b Accepted Date 2024-02-05 17:00:39 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Checkpoint Therapeutics, Inc. See All Filings	D	2023-04-14 17:00:18 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001651407 Filed Document 0001104659-23-045666 Exclusions or Exemptions 506b Accepted Date 2023-04-14 17:00:18 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Checkpoint Therapeutics, Inc. See All Filings	D	2023-03-03 17:15:43 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers H.C. Wainwright & Co. CIK Number 0001651407 Filed Document 0001104659-23-028508 Exclusions or Exemptions 506b Accepted Date 2023-03-03 17:15:43 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Checkpoint Therapeutics, Inc. See All Filings	D	2016-09-13 12:13:20 UTC
Amount To Be Raised $62,500,000 Associated Brokers / Dealers National Securities Corporation CIK Number 0001651407 Filed Document 0001578563-16-000018 Exclusions or Exemptions 506b Accepted Date 2016-09-13 12:13:20 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity